DiaMedica Therapeutics, Inc. (DMAC)
8.255
+0.24
(+2.93%)
USD |
NASDAQ |
Nov 20, 16:00
8.255
0.00 (0.00%)
After-Hours: 19:58
DiaMedica Therapeutics Gross Profit (TTM) : -0.046M for Sept. 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.046M |
| June 30, 2026 | -0.052M |
| March 31, 2026 | -0.043M |
| December 31, 2025 | -0.043M |
| September 30, 2025 | -0.043M |
| June 30, 2025 | -0.035M |
| March 31, 2025 | -0.042M |
| December 31, 2024 | -0.039M |
| September 30, 2024 | -0.036M |
| June 30, 2024 | -0.034M |
| March 31, 2024 | -0.048M |
| December 31, 2023 | -0.064M |
| September 30, 2023 | -0.062M |
| June 30, 2023 | -0.061M |
| March 31, 2023 | -0.043M |
| December 31, 2022 | -0.025M |
| September 30, 2022 | -0.025M |
| June 30, 2022 | -0.024M |
| March 31, 2022 | -0.024M |
| December 31, 2021 | -0.024M |
| September 30, 2021 | -0.023M |
| June 30, 2021 | -0.022M |
| March 31, 2021 | -0.021M |
| December 31, 2020 | -0.021M |
| September 30, 2020 | -0.021M |
| Date | Value |
|---|---|
| June 30, 2020 | -0.021M |
| March 31, 2020 | -0.021M |
| December 31, 2019 | -0.021M |
| September 30, 2019 | -0.016M |
| June 30, 2019 | 0.4887M |
| March 31, 2019 | 0.4917M |
| December 31, 2018 | 0.4937M |
| September 30, 2018 | 0.4924M |
| June 30, 2018 | -0.0108M |
| March 31, 2018 | -0.0108M |
| December 31, 2017 | -0.0062M |
| September 30, 2017 | -0.0048M |
| June 30, 2017 | -0.0018M |
| March 31, 2017 | -0.0012M |
| December 31, 2016 | -0.0023M |
| September 30, 2016 | -0.0028M |
| June 30, 2016 | -0.0034M |
| March 31, 2016 | -0.0023M |
| December 31, 2015 | -0.0045M |
| September 30, 2015 | -0.0041M |
| June 30, 2015 | -0.0034M |
| March 31, 2015 | -0.0047M |
| December 31, 2014 | -0.0026M |
| September 30, 2014 | -0.0034M |
| June 30, 2014 | -0.0043M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 422.57M |
| Nektar Therapeutics | 51.52M |
| Fortress Biotech, Inc. | 41.80M |
| ACADIA Pharmaceuticals, Inc. | 1.088B |
| Alnylam Pharmaceuticals, Inc. | 3.874B |